Orchid Buys Karalex Pharma for Generics Marketing Presence in the US
By Heather Cartwright
Pharma Deals Review: Vol 2010 Issue 7 (Table of Contents)
Published: 13 Sep-2010
DOI: 10.3833/pdr.v2010.i7.1373 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Orchid Chemicals & Pharmaceuticals has established a direct marketing facility in the US for its generic products by acquiring Karalex Pharma, a US-based generic marketing and sales service provider...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS